Bavarian Nordic
CPSE:BAVA Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 44 Fair Values set on narratives written by author
WA
Consensus Narrative from 2 Analysts
Chikungunya Vaccine Launch And Market Expansion Will Open Opportunities But Mpox Demand Uncertainties Could Pose Risks
Key Takeaways The chikungunya vaccine launch and expansion into new markets could significantly drive revenue and broaden customer base. Strategic manufacturing enhancements and growth in the Travel Health portfolio can improve supply chain resilience and net margins.
View narrativeDKK 305.00
FV
42.9% undervalued intrinsic discount-2.38%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
13 days ago author updated this narrative